Main Content
![Steve Manobianco, MBA](http://abzymetx.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![Steve Manobianco, MBA Slide](http://abzymetx.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![Steve Manobianco, MBA Slide](http://abzymetx.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![Steve Manobianco, MBA Slide](http://abzymetx.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![Steve Manobianco, MBA Slide](http://abzymetx.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![Steve Manobianco, MBA Slide](http://abzymetx.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![Steve Manobianco, MBA Slide](http://abzymetx.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
![Steve Manobianco, MBA Slide](http://abzymetx.com/wp-content/plugins/revslider/public/assets/assets/dummy.png)
Impacting the research, diagnosis and treatment of human diseases through our novel antibody discovery and optimization platform
© Abzyme Therapeutics, LLC. All Rights Reserved.
321 Jones Blvd, Royersford, PA 19468
610-205-9650 | [email protected]